339 related articles for article (PubMed ID: 8806878)
41. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
42. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems.
Fontaine SM; Mash EA; Hoyer PB; Sipes IG
Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809
[TBL] [Abstract][Full Text] [Related]
43. Interspecies difference in liver-specific functions and biotransformation of testosterone of primary rat, porcine and human hepatocyte in an organotypical sandwich culture.
Langsch A; Giri S; Acikgöz A; Jasmund I; Frericks B; Bader A
Toxicol Lett; 2009 Aug; 188(3):173-9. PubMed ID: 19428196
[TBL] [Abstract][Full Text] [Related]
44. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
[TBL] [Abstract][Full Text] [Related]
45. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 484():1-290. PubMed ID: 12571679
[TBL] [Abstract][Full Text] [Related]
46. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
47. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide.
Khojasteh-Bakht SC; Chen W; Koenigs LL; Peter RM; Nelson SD
Drug Metab Dispos; 1999 May; 27(5):574-80. PubMed ID: 10220485
[TBL] [Abstract][Full Text] [Related]
48. Cryopreservation of rat and mouse hepatocytes. II. Assessment of metabolic capacity using testosterone metabolism.
Swales NJ; Johnson T; Caldwell J
Drug Metab Dispos; 1996 Nov; 24(11):1224-30. PubMed ID: 8937857
[TBL] [Abstract][Full Text] [Related]
49. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 470():1-330. PubMed ID: 12579203
[TBL] [Abstract][Full Text] [Related]
50. NTP technical report on the toxicity studies of 2-Chloronitrobenzene (CAS No. 88-73-3) and 4-Chloronitrobenzene (CAS No. 100-00-5) Administered by Inhalation to F344/N Rats and B6C3F1 Mice.
Bucher J
Toxic Rep Ser; 1993 Jul; 33():1-F25. PubMed ID: 12209191
[TBL] [Abstract][Full Text] [Related]
51. NTP technical report on the toxicity studies of malachite green chloride and leucomalachite green (CAS Nos. 569-64-2 and 129-73-7) administered in feed to F344/N rats and B6C3F1 mice.
Culp SJ
Toxic Rep Ser; 2004 Jun; (71):1-F10. PubMed ID: 15213768
[TBL] [Abstract][Full Text] [Related]
52. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
53. NTP Toxicology and Carcinogenesis Studies of Acetonitrile (CAS No. 75-05-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Apr; 447():1-272. PubMed ID: 12594528
[TBL] [Abstract][Full Text] [Related]
54. Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine.
Jewell H; Maggs JL; Harrison AC; O'Neill PM; Ruscoe JE; Park BK
Xenobiotica; 1995 Feb; 25(2):199-217. PubMed ID: 7618347
[TBL] [Abstract][Full Text] [Related]
55. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan.
Jackson AF; Williams A; Recio L; Waters MD; Lambert IB; Yauk CL
Toxicol Appl Pharmacol; 2014 Jan; 274(1):63-77. PubMed ID: 24183702
[TBL] [Abstract][Full Text] [Related]
56. Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo.
Sandker GW; Vos RM; Delbressine LP; Slooff MJ; Meijer DK; Groothuis GM
Xenobiotica; 1994 Feb; 24(2):143-55. PubMed ID: 8017089
[TBL] [Abstract][Full Text] [Related]
57. 7-Ethoxycoumarin O-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions.
Bayliss MK; Bell JA; Wilson K; Park GR
Xenobiotica; 1994 Mar; 24(3):231-41. PubMed ID: 8009886
[TBL] [Abstract][Full Text] [Related]
58. Identification and pathway mapping of furan target proteins reveal mitochondrial energy production and redox regulation as critical targets of furan toxicity.
Moro S; Chipman JK; Antczak P; Turan N; Dekant W; Falciani F; Mally A
Toxicol Sci; 2012 Apr; 126(2):336-52. PubMed ID: 22240984
[TBL] [Abstract][Full Text] [Related]
59. The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance.
Vickers AE; Connors S; Zollinger M; Biggi WA; Larrauri A; Vogelaar JP; Brendel K
Drug Metab Dispos; 1993; 21(3):454-9. PubMed ID: 8100501
[TBL] [Abstract][Full Text] [Related]
60. Comparative metabolism of furan in rodent and human cryopreserved hepatocytes.
Gates LA; Phillips MB; Matter BA; Peterson LA
Drug Metab Dispos; 2014 Jul; 42(7):1132-6. PubMed ID: 24751574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
